List of CytRx patents

List of CytRx patents

List of Imprivata patents

List of Goss International patents

List of Digital Guardian (Company) patents

List of AI new product development companies

Founders educated at California College of the Arts

Patents where

Current Assignee

Name

is

CytRx

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 7745465 Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereof	Patent 7745465 was granted and assigned to CytRx on June, 2010 by the United States Patent and Trademark Office.		CytRx		United States Patent and Trademark Office	7745465	June 29, 2010
	‌ US Patent 7550457 Pharmaceutically effective compounds	Patent 7550457 was granted and assigned to CytRx on June, 2009 by the United States Patent and Trademark Office.		CytRx		United States Patent and Trademark Office	7550457	June 23, 2009
	‌ US Patent 7361655 Pharmaceutically effective compounds	Patent 7361655 was granted and assigned to CytRx on April, 2008 by the United States Patent and Trademark Office.		CytRx		United States Patent and Trademark Office	7361655	April 22, 2008
	‌ US Patent 7691849 Carboxamidine derivatives and their use in the treatment of vascular diseases	Patent 7691849 was granted and assigned to CytRx on April, 2010 by the United States Patent and Trademark Office.		CytRx		United States Patent and Trademark Office	7691849	April 6, 2010
	‌ US Patent 10328093 Anthracycline formulations	Patent 10328093 was granted and assigned to CytRx on June, 2019 by the United States Patent and Trademark Office.	CytRx	CytRx		United States Patent and Trademark Office	10328093	June 25, 2019
	‌ US Patent 10278981 Cytotoxic agents for the treatment of cancer	Patent 10278981 was granted and assigned to CytRx on May, 2019 by the United States Patent and Trademark Office.	CytRx	CytRx		United States Patent and Trademark Office	10278981	May 7, 2019
	‌ US Patent 7384936 Carboxamidine derivatives and their use in the treatment of vascular diseases	Patent 7384936 was granted and assigned to CytRx on June, 2008 by the United States Patent and Trademark Office.		CytRx		United States Patent and Trademark Office	7384936	June 10, 2008
	‌ US Patent 7148239 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof	Patent 7148239 was granted and assigned to CytRx on December, 2006 by the United States Patent and Trademark Office.		CytRx		United States Patent and Trademark Office	7148239	December 12, 2006
	‌ US Patent 10881678 Cytotoxic agents for the treatment of cancer	Patent 10881678 was granted and assigned to CytRx on January, 2021 by the United States Patent and Trademark Office.	CytRx	CytRx		United States Patent and Trademark Office	10881678	January 5, 2021
	‌ US Patent 7126002 Pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds	Patent 7126002 was granted and assigned to CytRx on October, 2006 by the United States Patent and Trademark Office.		CytRx		United States Patent and Trademark Office	7126002	October 24, 2006
	‌ US Patent 7045576 Adjuvants and copolymer compositions	Patent 7045576 was granted and assigned to CytRx on May, 2006 by the United States Patent and Trademark Office.		CytRx		United States Patent and Trademark Office	7045576	May 16, 2006

11 results

0 selected

11 results

0 selected